Colorectal cancer is the third leading cause of cancer death in the United States, with variation of up to 20-fold worldwide (Park et al, 2010). Added to this, epidemiological studies suggest that economic development and dietary habits are implicated in colon cancer incidence. (Johnson et al. 2007). Cancer (especially colon cancer) advances over a prolonged duration consisting of three stages: initiation, promotion, and progression. In order to reduce cancer’s symptoms and persistence, carcinogenesis can be delayed through the use of chemopreventives. The goal of chemprevention is to slow, block, or reverse the process of carcinogenesis by using the compound and its variations (Johnson et al. 2007). Consequently, there is a need for non-toxic